Press Release | Tue Feb 7, 2012 4:01pm EST

Pivotal study published in JAMA confirms potential of Novartis candidate vaccine BexseroR to help protect infants against devastating meningococcal serogroup B disease

* Reuters is not responsible for the content in this press release.